Gastroparesis in type2 Diabetic Patient
NCT05584462 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-01-17
Summary
Gastroparesis is defined by objective delaying of gastric emptying without any evidence of mechanical obstruction. Diabetic gastroparesis is a potential complication that occurs in the setting of poorly controlled diabetes, resulting from dysfunction in the coordination and function of the autonomic nervous system, neurons, and specialized pacemaker cells (interstitial cells of Cajal, ICC) of the stomach and intestine, and the smooth muscle cells of the gastrointestinal tract
Conditions
- Diabetic Gastroparesis
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Manal Ez Eldin · Assiut University
-
Marwa Abo kresha · Assiut University
-
Waleed Ahmed Mohamed · Assiut University
-
mena adly wahba · Assiut University
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2026-01-01
- Completion
- 2027-01-01
More Related Trials
-
Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
NCT03281577 ·Status: COMPLETED ·Phase: PHASE2
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus
NCT00889486 ·Status: COMPLETED ·Phase: PHASE2
-
GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
NCT05875636 ·Status: COMPLETED
-
An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus
NCT01286090 ·Status: TERMINATED ·Phase: PHASE4
-
Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
NCT02833415 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus
NCT00568620 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)
NCT01206582 ·Status: COMPLETED ·Phase: PHASE2
-
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
NCT02669524 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
NCT03544229 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
A Study of CNSA-001 in Women With Diabetic Gastroparesis
NCT03712124 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis
NCT00861809 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes
NCT04696159 ·Status: RECRUITING ·Phase: NA
-
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
NCT06461377 ·Status: RECRUITING ·Phase: PHASE4
-
Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176890 ·Status: UNKNOWN ·Phase: NA
-
Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
NCT02289846 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of GLP-1 Agonists on Gastric Volume
NCT05854979 ·Status: COMPLETED
-
New Imaging Procedure for the Localisation of Insulinoma
NCT02127541 ·Status: COMPLETED ·Phase: NA
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Influence of Central Nervous Insulin Sensitivity on Insulin Secretion
NCT02870361 ·Status: COMPLETED ·Phase: NA
-
Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
NCT02308254 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
NCT00937079 ·Status: COMPLETED
-
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
NCT02655770 ·Status: COMPLETED ·Phase: PHASE4